Ubs Group Ag Stereotaxis, Inc. Transaction History
Ubs Group Ag
- $611 Billion
- Q3 2025
A detailed history of Ubs Group Ag transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 83,888 shares of STXS stock, worth $185,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,888
Previous 70,382
19.19%
Holding current value
$185,392
Previous $149,000
71.81%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding STXS
# of Institutions
111Shares Held
43MCall Options Held
13.8KPut Options Held
31.4K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.2 Million11.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.71MShares$10.4 Million8.41% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$7.6 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.31 Million10.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $165M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...